Guaifenesin 200mg
- Product NDC
- 69517-148
- 11-digit product format
- 695170148
- Labeler code
- 69517
- Product ID
- 69517-148_d6aa4904-e177-47a3-e053-2a95a90a6139
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- HEALTHLIFE OF USA LLC
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-01-28
- Marketing end
- 0000-00-00
- Substance
- GUAIFENESIN
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69517-148-03 | Guaifenesin 200mg | 300 in 1 BOTTLE | TABLET | 300 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69517-148 | GUAIFENESIN 200MG (GUAIFENESIN) TABLET [HEALTHLIFE OF USA LLC] | 2 | Legacy NDC, 1 package rows | 20231021_d6aa1493-bc22-a318-e053-2995a90a6381.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69517-148-03 | 69517014803 | 300 TABLET in 1 BOTTLE (69517-148-03) | 300 tablet | 2022-01-28 | 0000-00-00 | No | No | Current |